Dengue Fever: .

OBJECTIVES

This study aimed to assess the mortality rate and related factors in dengue fever (DF) patients. Additionally, it will outline the clinical and biochemical characteristics and treatments administered to confirmed cases.

METHODS

This retrospective cross-sectional study included DF patients who presented to Sultan Qaboos University Hospital between January 2022 and July 2023. Data were extracted from the hospital's electronic system into a pre-designed Excel data collection sheet and analysed.

RESULTS

The study identified 319 confirmed DF cases with male predominance. The overall mortality rate was 3.8% (n = 12). Mortality was significantly higher among those with ischaemic heart disease (41.7%; n = 5), chronic kidney disease (25%; n = 3) and those on aspirin (25%; n = 3). Patients presenting with fever, headache, arthralgia and body aches, along with multi-organ involvement, exhibited confusion, lower platelet counts, abnormalities in haematocrit and haemoglobin levels, as well as deranged liver and renal function. Backward stepwise multivariate regression analysis showed that the use of antibiotics (odds ratio [OR] = 6.644, 95% confidence interval [CI]: 1.202-36.742; = 0.030) and elevated bilirubin levels (OR = 1.058, 95% CI: 1.013-1.105; = 0.011) were significant independent predictors of mortality.

CONCLUSIONS

This study identified a mortality rate of 3.8% among patients with DF. Elevated bilirubin levels and antibiotic use during hospitalisation are independent predictors of mortality. Therefore, it is recommended that such patients be closely monitored for potential signs, symptoms and biochemical changes to reduce the risk of mortality.